News

Vivos Therapeutics to Share Insights on Innovative Sleep Solutions

Vivos Therapeutics to Share Insights on Innovative Sleep Solutions

Vivos Therapeutics Engages in Dialogue on Sleep Disorder Innovations

Vivos Therapeutics, Inc. (NASDAQ: VVOS), a pioneering medical device firm, has announced its participation in an upcoming fireside chat. The company's CEO, Kirk Huntsman, is set to engage in a significant discussion with Do Kim, a senior research analyst from Water Tower Research. This event will take place soon, providing a platform for Vivos to highlight its groundbreaking strategies and innovations in addressing sleep-related breathing disorders.

Overview of the Fireside Chat Discussion

During the fireside chat, Mr. Huntsman will elaborate on the essential aspects of the company and introduce the Vivos CARE devices designed specifically for obstructive sleep apnea (OSA) treatments. He will also discuss the strategic transition of Vivos towards a medical-centric business model. This shift aims to enhance collaborations with physician sleep practice groups, thereby facilitating better treatment options for OSA.

Understanding the Vivos CARE Treatment Method

The Vivos CARE devices represent a leap forward in treating patients with sleep apnea, effectively addressing a prevalent issue faced by millions. With a comprehensive understanding of market dynamics, Vivos aims to integrate its devices into the treatment paradigm for OSA. These innovative appliances are designed not just to alleviate symptoms but also to contribute to an overall improvement in patients' quality of life.

Expanding Outreach and Partnerships

Central to Vivos' approach is forging partnerships with physician-based sleep therapy groups, which is vital for disseminating the benefits of their technology. By actively collaborating with these groups, Vivos not only expands its outreach but also enhances the accessibility of its treatments to diverse patient populations.

The Vivos Method: A Closer Look

Vivos Therapeutics has pioneered the Vivos Method, which offers a non-invasive, non-surgical solution for treating sleep disorders. This method has shown clinical efficacy in treating obstructive sleep apnea in both adults and children, representing a cost-effective and practical approach in the field. The device's design focuses on restructuring the upper airway's anatomy, promoting better airflow and reducing OSA symptoms significantly.

Comprehensive Patient Care and Technology

In addition to the Vivos CARE devices, the company offers a unique diagnostic technology known as SleepImage, included in their VivoScore program for home sleep testing. This initiative provides an essential service that allows patients to diagnose sleep issues conveniently and effectively, reinforcing Vivos' commitment to integrating technology with patient care.

Training and Support for Providers

Vivos ensures that dental and medical professionals are well-equipped to provide these innovative treatments through its Vivos Integrated Practice (VIP) program. This program offers extensive training, resources, and ongoing support for practitioners, enhancing their abilities to deliver the Vivos Method effectively to their patients.

Conclusion and Future Outlook for Vivos Therapeutics

As Vivos Therapeutics moves forward, the focus remains on redefining how sleep-related conditions are treated. With a dedicated team and a solid backing of research, Vivos is positioning itself as a leader in the medical technology sector. The insights shared during the upcoming fireside chat are expected to shed light on the exciting developments that lie ahead for the company.

Frequently Asked Questions

What is the purpose of the fireside chat involving Vivos Therapeutics?

The chat will provide insights into Vivos' business strategies and its innovative treatments for sleep-related disorders, focusing on the Vivos CARE devices.

Who will be speaking at the event?

Kirk Huntsman, CEO of Vivos Therapeutics, will discuss the company's methodologies and partnerships with Do Kim from Water Tower Research.

What is the Vivos Method?

The Vivos Method is a non-invasive treatment approach designed to address obstructive sleep apnea (OSA), enhancing the overall quality of life for patients.

How can healthcare providers benefit from working with Vivos?

Healthcare providers receive extensive training and support through the Vivos Integrated Practice program, facilitating effective use of the Vivos Method.

Is there a way for patients to access the fireside chat recording?

Yes, the replay of the fireside chat will be available for 30 days in the Investor Relations section on Vivos' website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Evaluating xAI's Ambitious $230 Billion Valuation Against OpenAI

Updated Category News Views 456

Evaluating xAI's Valuation Dynamics Elon Musk's xAI, led by the visionary CEO of Tesla Inc (NASDAQ: TSLA), is reportedly pursuing an impressive capital raise of $15 billion. This comes at a staggering valuation of $230 billion. It's a bold move for a relatively new player still enhancing its offerings like Grok. With OpenAI standing tall at nearly $500 billion, this...

Continue Reading
Sharps Technology Partners with Jupiter to Boost Solana Growth

Updated Category News Views 162

Sharps Technology and Jupiter Exchange Join Forces for Solana Expansion Sharps Technology, Inc. (NASDAQ: STSS), a prominent player in the medical device sector, is set to make significant waves in the blockchain space through its recent partnership with Jupiter Exchange. This strategic alliance aims to enhance the adoption of Solana, a high-performance blockchain designed...

Continue Reading
United Fire Group Set to Discuss Third Quarter Earnings in 2025

Updated Category News Views 195

United Fire Group, Inc. Earnings Call Announcement United Fire Group, Inc. (NASDAQ: UFCS), has officially announced the date for its earnings conference call concerning its third-quarter results. This important call is set to occur on Wednesday, November 5, 2025, at 9 a.m. CT, following the release of the financial results after market close on November 4, 2025. This...

Continue Reading
AmpliTech Group Completes $1.4 Million Offering Successfully

Updated Category News Views 108

AmpliTech Group Completes Successful Fundraising AmpliTech Group, Inc. (NASDAQ: AMPG) has made headlines recently with the successful closing of its registered direct offering. Through this initiative, they managed to raise a significant amount, totaling approximately $1.475 million. This amount was acquired through the sale of 1,603,259 shares of common stock, priced at...

Continue Reading
Arkay Beverages Seeks Investment to Drive Global Expansion

Updated Category News Views 289

Arkay Beverages Launches New Investment Round Arkay Beverages, a global leader in alcohol-free spirits, is excited to announce its latest investment initiative aimed at raising $150 million to further its mission of dominating the thriving zero-proof beverage market. Strategic Goals and Financial Objectives This funding will significantly assist Arkay in enhancing its...

Continue Reading